Original Source(s)
Related Content
Gastrointestinal Cancers and Clinical Trials: What Patients Need to Know Earlier On
Breakthrough treatments for gastrointestinal cancers are being tested in clinical trials right now.
Rethinking Progress in Clinical Trials
Three clinical development leaders discuss how early signals, trial design, regulatory expectations, and patient access are reshaping clinical development
May 20, 2026
-
11 min
Roswell Park Experts Report on Discovery of Rare Bladder Cells, Neural Mapping of Pelvic Floor Muscles at AUA 2026
Evidence provided by a Roswell Park study indicates that neoadjuvant chemotherapy may be the preferred course of treatment for patients with non-muscle-invasive bladder cancer (NMIBC) when their disease progresses and they are diagnosed with muscle-invasive bladder cancer (MIBC)
